|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.67 USD | -8.25% |
|
-18.26% | -12.83% |
CureVac N.V. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 12.37 million compared to EUR 7.13 million a year ago. Net loss was EUR 70.55 million compared to EUR 57.42 million a year ago.
Basic loss per share from continuing operations was EUR 0.31 compared to EUR 0.27 a year ago. Diluted loss per share from continuing operations was EUR 0.31 compared to EUR 0.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.83% | 823M | |
| +40.80% | 53.67B | |
| +35.79% | 38.86B | |
| -8.05% | 38.76B | |
| -8.98% | 27.27B | |
| +10.69% | 25.91B | |
| -16.21% | 20.29B | |
| +31.00% | 12.78B | |
| +28.51% | 12.18B | |
| -1.67% | 11.96B |
CUREVAC N.V. 
